Pfizer’s recent announcement regarding sales of its branded products on a not-for-profit – at cost – basis to low- and lower-middle-jncome countries may prove to be a real game-changer in global health, particularly if other companies follow suit.
Pfizer’s recent announcement regarding sales of its branded products on a not-for-profit – at cost – basis to low- and lower-middle-jncome countries may prove to be a real game-changer in global health, particularly if other companies follow suit.